Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Crossref DOI link: https://doi.org/10.1186/s13045-017-0518-8
Published Online: 2017-09-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Foss, Francine
Horwitz, Steven
Pro, Barbara
Miles Prince, H.
Sokol, Lubomir
Balser, Barbara
Wolfson, Julie
Coiffier, Bertrand